Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,391.97
(
-0.12%
)
US TECH 100
28,248.00
(
-0.15%
)
Dow Jones
49,526.49
(
-0.47%
)
Brent Oil
105.82
(
0.05%
)
Bitcoin
79,702.60
(
-0.98%
)
News Focus
News Focus
Post# of 825900
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

exwannabe

Send PM Follow Ignore
Followers 92
Posts 20563
Boards Moderated 0
Alias Born 09/06/2006

exwannabe

Re: williamssc post# 817900

Monday, 03/16/2026 10:53:49 AM

Monday, March 16, 2026 10:53:49 AM

Post# of 825900

Yes. Due to DCVax-L being a very personalized cell therapy with manufacturing and handling in Sawston UK, location would play a huge role in seeking first approval. Why not the FDA first? well that's the reason.


Yet, NWBO spent a large chunk of money expanding the Cognate capacity to support a US launch.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News